| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.52▲ | 6.59▼ | 6.68▼ | 6.77▼ | 5.77▲ |
| MA10 | 6.68▼ | 6.73▼ | 6.72▼ | 6.51▼ | 4.80▲ |
| MA20 | 6.74▼ | 6.78▼ | 6.78▼ | 5.88▲ | 4.19▲ |
| MA50 | 6.77▼ | 6.56▲ | 6.37▲ | 4.62▲ | 5.52▲ |
| MA100 | 6.45▲ | 6.12▲ | 5.79▲ | 4.07▲ | N/A |
| MA200 | 6.04▲ | 5.28▲ | 4.89▲ | 4.98▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.044▼ | -0.057▼ | -0.061▼ | 0.032▲ | 0.463▲ |
| RSI | 39.806▼ | 44.320▼ | 46.845▼ | 64.070▲ | 64.560▲ |
| STOCH | 5.790▼ | 21.711 | 28.006 | 74.253 | 86.398▲ |
| WILL %R | -75.000▼ | -75.000▼ | -79.365▼ | -36.245 | -18.864▲ |
| CCI | -89.557 | -114.564▼ | -149.251▼ | 42.988 | 165.598▲ |
|
Thursday, September 11, 2025 01:37 PM
enGene (NASDAQ:ENGN), a clinical-stage gene therapy company advancing treatments for bladder cancer, released its fiscal 2025 third-quarter earnings on Sept. 11, 2025. The period was highlighted by ...
|
|
Thursday, September 11, 2025 09:03 AM
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral gene therapy company, today announced its financial results for the ...
|
|
Wednesday, September 10, 2025 02:25 PM
enGene Holdings Inc. ( NASDAQ: ENGN) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 1:50 PM EDT ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/25 | 7.00 | 7.00 | 6.24 | 6.50 | 43,833 |
| 24/09/25 | 6.7697 | 6.99 | 6.6017 | 6.98 | 33,919 |
| 23/09/25 | 6.81 | 7.15 | 6.71 | 6.76 | 70,822 |
| 22/09/25 | 6.85 | 7.005 | 6.4617 | 6.81 | 42,063 |
| 19/09/25 | 6.97 | 7.33 | 6.6338 | 6.82 | 61,437 |
| 18/09/25 | 6.5093 | 7.05 | 6.44 | 6.96 | 2,322,048 |
| 17/09/25 | 6.13 | 6.52 | 6.02 | 6.52 | 597,859 |
| 16/09/25 | 6.08 | 6.35 | 5.925 | 6.065 | 152,097 |
| 15/09/25 | 5.71 | 6.05 | 5.60 | 5.97 | 51,547 |
| 12/09/25 | 6.06 | 6.54 | 5.5201 | 5.71 | 86,050 |
|
|
||||
|
|
||||
|
|